Evaluation of the validity and screening performance of a revised single‐item fear of cancer recurrence screening measure (FCR‐1r)

Fear of cancer recurrence (FCR) is highly prevalent among cancer survivors, but irregularly identified in practice. Single‐item FCR measures suitable for integration into broader psychosocial screening are needed. This study evaluated the validity of a revised version of the original FCR‐1 (FCR‐1r) and screening performance alongside the Edmonton Symptom Assessment System – Revised (ESAS‐r) anxiety item.

[1]  J. Custers,et al.  Evaluating the capacity of the distress thermometer to detect high fear of cancer recurrence , 2022, Psycho-oncology.

[2]  M. Jefford,et al.  Study protocol for the evaluation of Fear-Less: a stepped-care program for fear of cancer recurrence in survivors with early-stage disease , 2022, Pilot and Feasibility Studies.

[3]  J. Custers,et al.  Interventions addressing fear of cancer recurrence: challenges and future perspectives , 2022, Current opinion in oncology.

[4]  N. D. de Wit,et al.  What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis , 2022, Psycho-oncology.

[5]  E. Philip,et al.  Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? , 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[6]  M. Bendiane,et al.  Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey , 2022, Journal of Cancer Survivorship.

[7]  Wengao Li,et al.  Fear of Recurrence in Chinese Cancer Patients: Prevalence, Correlates, and Network Analysis , 2022, Frontiers in Psychiatry.

[8]  A. Girgis,et al.  A systematic mixed studies review of fear of cancer recurrence in families and caregivers of adults diagnosed with cancer , 2021, Journal of Cancer Survivorship.

[9]  P. Butow,et al.  A Systematic Review of Fear of Cancer Recurrence Among Indigenous and Minority Peoples , 2021, Frontiers in Psychology.

[10]  A. Smith,et al.  A systematic review of fear of cancer recurrence related healthcare use and intervention cost‐effectiveness , 2021, Psycho-oncology.

[11]  R. Zachariae,et al.  Spotlight on the Fear of Cancer Recurrence Inventory (FCRI) , 2020, Psychology research and behavior management.

[12]  L. Heathcote,et al.  Fear of cancer recurrence in childhood cancer survivors: A developmental perspective from infancy to young adulthood , 2020, Psycho-oncology.

[13]  A. Smith.  Integrating fear of cancer recurrence screening into routine care: opportunities and challenges , 2020, Psycho-oncology.

[14]  C. Gélinas,et al.  The FCR‐1: Initial validation of a single‐item measure of fear of cancer recurrence , 2020, Psycho-oncology.

[15]  P. Butow,et al.  Identifying the key characteristics of clinical fear of cancer recurrence: An international Delphi study , 2019, Psycho-oncology.

[16]  M. Jefford,et al.  Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review , 2019, Asia-Pacific journal of clinical oncology.

[17]  S. Simard,et al.  Effect of Psychological Intervention on Fear of Cancer Recurrence: A Systematic Review and Meta-Analysis , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Butow,et al.  Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors , 2019, Supportive Care in Cancer.

[19]  W. Lam,et al.  Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism , 2019, Psycho-oncology.

[20]  J. Custers,et al.  Re‐validation and screening capacity of the 6‐item version of the Cancer Worry Scale , 2018, Psycho-oncology.

[21]  P. Butow,et al.  Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study , 2018, Supportive Care in Cancer.

[22]  P. Butow,et al.  Exploring the screening capacity of the Fear of Cancer Recurrence Inventory‐Short Form for clinical levels of fear of cancer recurrence , 2018, Psycho-oncology.

[23]  C. Maheu,et al.  The fear of cancer recurrence literature continues to move forward: a review article , 2017, Current opinion in supportive and palliative care.

[24]  S. Rogers,et al.  Fear of cancer recurrence in oral and oropharyngeal cancer patients: An investigation of the clinical encounter , 2018, European journal of cancer care.

[25]  R. Trevethan,et al.  Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice , 2017, Front. Public Health.

[26]  P. Butow,et al.  From normal response to clinical problem: definition and clinical features of fear of cancer recurrence , 2016, Supportive Care in Cancer.

[27]  P. Butow,et al.  Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation , 2016, Journal of Cancer Survivorship.

[28]  J. Savard,et al.  Screening and comorbidity of clinical levels of fear of cancer recurrence , 2015, Journal of Cancer Survivorship.

[29]  J. Fardell,et al.  The sum of all fears: conceptual challenges with measuring fear of cancer recurrence , 2015, Supportive Care in Cancer.

[30]  P. Butow,et al.  The Concerns About Recurrence Questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors , 2015, Journal of Cancer Survivorship.

[31]  P. Butow,et al.  Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals , 2014, Psycho-oncology.

[32]  P. Butow,et al.  Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross‐sectional study , 2013, Psycho-oncology.

[33]  E. Grunfeld,et al.  Factors reported to influence fear of recurrence in cancer patients: a systematic review , 2013, Psycho-oncology.

[34]  Gerry Humphris,et al.  Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies , 2013, Journal of Cancer Survivorship.

[35]  H. Brenner,et al.  Fear of recurrence and disease progression in long‐term (≥5 years) cancer survivors—a systematic review of quantitative studies , 2013, Psycho-oncology.

[36]  J. Mandrekar.  Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[37]  Joshua D. Clapp,et al.  The impact of event scale-revised: psychometric properties in a sample of motor vehicle accident survivors. , 2008, Journal of anxiety disorders.

[38]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[39]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[40]  Adrian Wells,et al.  A short form of the metacognitions questionnaire: properties of the MCQ-30. , 2004, Behaviour research and therapy.

[41]  Eduardo Bruera,et al.  The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients , 1991, Journal of palliative care.